Fonte: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Assuntos: POLIMORFISMO, DISFUNÇÃO ERÉTIL
ABNT
LACCHINI, Riccardo et al. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, v. 18, n. 2, p. 238-244, 2018Tradução . . Disponível em: https://doi.org/10.1038/tpj.2017.2. Acesso em: 05 nov. 2024.APA
Lacchini, R., Muniz, J. J., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2018). Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, 18( 2), 238-244. doi:10.1038/tpj.2017.2NLM
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/tpj.2017.2Vancouver
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/tpj.2017.2